Bank Of Montreal Amphastar Pharmaceuticals, Inc. Transaction History

Bank Of Montreal

$197 Billion
Q2 2024

A detailed history of Bank Of Montreal transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Bank Of Montreal holds 7,654 shares of AMPH stock, worth $367,545. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,654

Previous 7,646 0.1%

Holding current value

$367,545

Previous $335,000 8.66%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$38.65 - $43.48 $309 - $347	8 Added 0.1%	7,654 $306,000
Q1 2024 May 13, 2024	BUY	$42.85 - $63.45 $8,570 - $12,690	200 Added 2.69%	7,646 $335,000
Q4 2023 Feb 08, 2024	SELL	$44.49 - $62.93 $24,291 - $34,359	-546 Reduced 6.83%	7,446 $460,000
Q3 2023 Nov 01, 2023	SELL	$45.51 - $65.0 $24,757 - $35,360	-544 Reduced 6.37%	7,992 $367,000
Q2 2023 Aug 02, 2023	BUY	$35.77 - $58.38 $40,133 - $65,502	1,122 Added 15.13%	8,536 $490,000
Q1 2023 Jun 13, 2024	BUY	$27.99 - $37.92 $30,565 - $41,408	1,092 Added 14.28%	8,738 $327,000
Q4 2022 Feb 01, 2023	BUY	$27.93 - $31.27 $16,702 - $18,699	598 Added 8.77%	7,414 $207,000
Q3 2022 Nov 10, 2022	BUY	$27.56 - $37.75 $8,846 - $12,117	321 Added 4.94%	6,816 $222,000
Q2 2022 Aug 11, 2022	SELL	$29.79 - $42.29 $194,647 - $276,322	-6,534 Reduced 50.15%	6,495 $223,000
Q1 2022 May 12, 2022	BUY	$22.96 - $36.45 $8,518 - $13,522	371 Added 2.93%	13,029 $477,000
Q4 2021 Feb 11, 2022	SELL	$18.14 - $23.29 $30,094 - $38,638	-1,659 Reduced 11.59%	12,658 $298,000
Q3 2021 Nov 12, 2021	SELL	$17.83 - $21.49 $27,654 - $33,330	-1,551 Reduced 9.77%	14,317 $279,000
Q2 2021 Aug 12, 2021	BUY	$17.11 - $20.92 $271,501 - $331,958	15,868 New	15,868 $331,000

Others Institutions Holding AMPH

# of Institutions

279

Shares Held

34.2M

Call Options Held

25.5K

Put Options Held

24.8K

View Full List

About Amphastar Pharmaceuticals, Inc.

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $2.35B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

More about AMPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.

Account